Londonderry, February 07, 2017 – IBA (Ion Beam Applications S.A.), the global high-tech leader in the next generation of proton therapy solutions and radiation therapy quality assurance for the treatment of cancer, announces the first clinical implementation of Dolphin Online Ready Patient QA and Monitoring solution in the United Kingdom.
With the use of Dolphin attached to the hospital’s TrueBeam™ treatment machine, the team at the North West Cancer Centre in Londonderry, Northern Ireland, set a new standard for high quality cancer therapy and a more efficient patient Quality Assurance (QA) process. This milestone allows the clinic to offer their patients the latest generation of technology to deliver highest quality radiation therapy treatments.
“With Dolphin we can perform fully independent, measurement-based quality assurance of our most advanced IMRT and VMAT treatments quickly and confidently.” says Dr Andrew Reilly, Head of Radiotherapy Physics at the new North West Cancer Centre, Londonderry. He continues, “Being so straightforward to use it allows us to plan to the capabilities of the treatment machines, rather than limiting what we do because legacy verification processes cannot keep up. This ensures our clinicians can offer the best possible care to their patients.” Dr Wendy Hyland, Radiotherapy Physicist adds: “The measurement process is so easy I can spend more time thinking about what the results mean rather than worrying about the measurements themselves.”

Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About the Dolphin System
Dolphin is a complete solution that offers a higher capability to detect and verify possible treatment dose discrepancies compared to conventional QA solutions, thus contributing to a more efficient and safer radiation therapy. This improvement is based on Dolphin’s significantly higher treatment dose measurement resolution.
Highly complex IMRT and rotational treatment plans are delivered and measured with the Dolphin transmission detector prior to each patient treatment. A sophisticated TPS-Class software allows verification of dose deviations in 3D patient anatomy between the plan and actual delivered dose measured with Dolphin.
The hospital’s patient QA workflow efficiency is increased with Dolphin’s “plug and play” wireless setup and its automatic verification software displaying instant QA results.
The Dolphin solution including the detector and the software is “online ready” and currently used for pre-treatment QA. The system will be capable of measuring the actual patient treatment dose in online mode, fraction by fraction. The online capability is currently pending release. For more information visit http://www.iba-dosimetry.com/